Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467746) titled 'Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids' on March 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: The Third Xiangya Hospital of Central South University

Condition: Amyotrophic Lateral Sclerosis

Intervention: Drug: C. cicadae

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 2026

Target Sample Size: 84

To know more, visit ht...